nanjing pharmaceutical co-a
(600713:Shanghai)
Transactions by NANJING PHARMACEUTICAL CO-A (600713) in the last 6 months
Nanjing Zhongshan Creative Industry Development Co., Ltd. agreed to acquire 41% stake in Zhongjian Zhikang Supply Chain Services Co., Ltd from NanJing Pharmaceutical Company Limited (SHSE:600713) for approximately 170 million on December 11, 2012. In a related deal, NanJing Pharmaceutical Company Limited agreed to sell 16.85% of Xinjiang Production and Construction Corps Medical Co., Ltd. and 12.63% of Xinjiang Qikang Habo Uygur Medicine Co., Ltd. The deal is subject ...
Read More
Xinjiang Tianyuan Health Industry Co., Ltd. agreed to acquire 16.85% stake in Xinjiang Production and Construction Corps Medical Co., Ltd. from NanJing Pharmaceutical Company Limited (SHSE:600713) for CNY 7.2 million on December 11, 2012. In a related transaction, NanJing Pharmaceutical agreed to sell 41% stake of Zhongjian Zhikang Supply Chain Service Co., Ltd. and 12.63% stake of Xinjiang Qikang Habo Uygur Medicine Co., Ltd. On completion, NanJing Pharmaceutical Company ...
Read More
| Recently Viewed | |||
| 600713:CH | CNY4.75 CNY | -0.01 | |
| Company | Last | Change | |
| No competitor information is available for 600713. | |||
| View Industry Companies | |||
Industry Analysis
600713
Industry Average
| Valuation | 600713 | Industry Range |
| Price/Earnings | 86.7x |
|
| Price/Sales | 0.2x |
|
| Price/Book | 3.3x |
|
| Price/Cash Flow | 89.0x |
|
| TEV/Sales | NM | Not Meaningful |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- New York, NY | New York UniversityPosted: Apr 19
Sponsored Financial Commentaries
Sponsored Links
To contact NANJING PHARMACEUTICAL CO-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








